SBRI Healthcare provides funding and support to early-stage projects, enabling testing for business feasibility and technology development, as well as to more mature products by supporting real-world implementation studies. 

The competitions aim to accelerate innovative technologies in the NHS and the wider health and social care system, tackling unmet health and care needs.

Funding is available for phase 1 and 3 of the competition, looking for innovations that can help stroke services, urgent and emergency care, women’s health and Antimicrobial Resistance (AMR).

Competition 25 – AMR and women’s health

Applications close 28 August 2024 1pm. Projects will commence in January 2025. Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and will last for six months.

Competition 26 – Urgent & emergency care and stroke 

Applications close 18 September 2024, 1pm. Projects are scheduled to start between January and February 2025. Contracts will last up to 12 months and are valued at up to £500,000 (NET) per project.

Find out more via SBRI’s website. 

Latest Opportunities

Single manufacturer & supplier required for human skin patch: Formulation, manufacture, and packing

Opportunity Company:  Nottingham-based MedTech company Requires: Seeking a single manufacturer and supplier for the formulation,…

Medilink Midlands Job Vacancy - Innovation Adviser

About the job Innovation Adviser – Midlands region – Full time salary £40-45K – Home…

Global Business Innovation Programme: Health & Medical Technologies - Singapore

Innovate UK is inviting ambitious innovative companies to participate in its Global Business Innovation Programme…

Latest News

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep – Helping Gamers…

Kindeva Opens New UK HQ and Manufacturing Site for the Development of Next-Generation Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters…

EU MDR/IVDR Revision: A Gateway for Chinese Innovators Entering UK and EU Markets via EFEC

In a significant move for the global medtech landscape, the European Commission has initiated a…